| Catalog | name | Description | price |
|---|---|---|---|
| R-R-4178 | INCB 3284 CAS No.887401-92-5 | INCB 3284/CAS No.887401-92-5 is a potent, selective and orally bioavailable human CCR2 antagonist, inhibiting monocyte chemoattractant protein-1 binding to hCCR2, with an IC50 of 3.7 nM. INCB 3284 can be used in the research of acute liver failure. | price> |
| R-R-4179 | MK-0812 Succinate CAS No.851916-42-2 | MK-0812 Succinate/CAS No.851916-42-2 is a potent and selective CCR2 antagonist with high affinity at CCR2. | price> |
| R-R-4180 | SB-328437 CAS No.247580-43-4 | SB-328437/CAS No.247580-43-4 is a potent, selective non-peptide CCR3 antagonist with an IC50 of 4.5 nM. | price> |
| R-R-4181 | ML604086 CAS No.850330-18-6 | ML604086/CAS No.850330-18-6 is a selective CCR8 inhibitor, inhibiting CCL1 binding to CCR8 on circulating T-cells. ML604086 inhibits CCL1 mediated chemotaxis and increases in intracellular Ca2+ concentrations. | price> |
| R-R-4182 | ALK4290 CAS No.1251528-23-0 | ALK4290 (AKST4290)/CAS No.1251528-23-0 is a potent and orally active CCR3 inhibitor extracted from patent US20130261153A1, compound Example 2, with a Ki of 3.2 nM for hCCR3. ALK4290 can be used for the research of neovascular age-related macular degeneration and Parkinsonism. | price> |
| R-R-4183 | PF-07054894 CAS No.2413693-96-4 | PF-07054894/CAS No.2413693-96-4 is a potent CCR6 antagonist. PF-07054894 targets G protein-coupled receptor (GPCR). PF-07054894 can be used in research of inflammatory bowel disease. | price> |
| R-R-4184 | BMS CCR2 22 CAS No.445479-97-0 | BMS CCR2 22/CAS No.445479-97-0 is a potent, specific and high affinity CC-type chemokine receptor 2 (CCR2) antagonist with excellent binding affinity (binding IC50 of 5.1 nM) and potent functional antagonism (calcium flux IC50 of 18 nM and chemotaxis IC50 of 1 nM). | price> |
| R-R-4185 | CCR2 antagonist 1 CAS No.1683534-96-4 | CCR2 antagonist 1/CAS No.1683534-96-4 is a high-affinity and long-residence-time CCR2 antagonist, with a Ki of 2.4 nM. | price> |
| R-R-4186 | SB297006 CAS No.58816-69-6 | SB297006/CAS No.58816-69-6 is a CCR3 antagonist, which significantly inhibits proliferation and neurosphere formation in CCL11-treated neural progenitor cells. | price> |
| R-R-4187 | GSK2239633A CAS No.1240516-71-5 | GSK2239633A/CAS No.1240516-71-5 is a CC-chemokine receptor 4 (CCR4) antagonist, which inhibits the binding of [125I]-TARC to human CCR4 with a pIC50 of 7.96 ± 0.11. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


